The ins and outs of osteopontin

Oncoimmunology. 2015 Apr 2;4(3):e978711. doi: 10.4161/2162402X.2014.978711. eCollection 2015 Mar.

Abstract

The continuous remodeling of progressing tumors demands non-physiologic production of extracellular matrix (ECM) proteins. Among them, osteopontin (OPN) has been largely involved in tumor progression and metastasis. We have recently discovered a new mechanism for OPN in the metastatic spread of mammary carcinoma providing local immunosuppression at the seeding site.

Keywords: metastasis; myeloid-derived suppressor cells; osteopontin.